Arden Trust’s Biogen BIIB Stock Holding History

Arden Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$413K	Hold	1,781	–	–	0.06%	154
2024 Q1	$384K	Sell	1,781 -155	-8%	-$36.3K	0.05%	171
2023 Q4	$501K	Sell	1,936 -449	-19%	-$110K	0.07%	144
2023 Q3	$613K	Buy	2,385 +6	+0.3%	+$1.6K	0.1%	125
2023 Q2	$678K	Sell	2,379 -1,055	-31%	-$314K	0.11%	118
2023 Q1	$955K	Sell	3,434 -590	-15%	-$163K	0.17%	115
2022 Q4	$1.11M	Sell	4,024 -399	-9%	-$113K	0.23%	97
2022 Q3	$1.18M	Sell	4,423 -88	-2%	-$18.7K	0.3%	81
2022 Q2	$920K	Sell	4,511 -949	-17%	-$194K	0.21%	112
2022 Q1	$1.15M	Sell	5,460 -345	-6%	-$75K	0.23%	100
2021 Q4	$1.39M	Sell	5,805 -2,874	-33%	-$739K	0.24%	91
2021 Q3	$2.46M	Sell	8,679 -153	-2%	-$50.1K	0.42%	47
2021 Q2	$3.06M	Buy	8,832 +362	+4%	+$110K	0.5%	40
2021 Q1	$2.37M	Buy	8,470 +1,184	+16%	+$319K	0.4%	47
2020 Q4	$1.78M	Sell	7,286 -1,121	-13%	-$289K	0.3%	65
2020 Q3	$2.38M	Sell	8,407 -1,321	-14%	-$368K	0.43%	43
2020 Q2	$2.6M	Buy	9,728 +1,299	+15%	+$390K	0.48%	39
2020 Q1	$2.67M	Buy	8,429 +141	+2%	+$42.8K	0.53%	31
2019 Q4	$2.46M	Sell	8,288 -450	-5%	-$125K	0.39%	54
2019 Q3	$2.03M	Buy	8,738 +1	+0%	+$233	0.33%	62
2019 Q2	$2.04M	Sell	8,737 -3,009	-26%	-$695K	0.35%	61
2019 Q1	$2.78M	Sell	11,746 -957	-8%	-$301K	0.45%	42
2018 Q4	$3.82M	Sell	12,703 -247	-2%	-$78.8K	0.69%	26
2018 Q3	$4.58M	Sell	12,950 -317	-2%	-$109K	0.71%	20
2018 Q2	$3.85M	Buy	13,267 +1,311	+11%	+$369K	0.61%	25
2018 Q1	$3.27M	Sell	11,956 -345	-3%	-$107K	0.51%	35
2017 Q4	$3.92M	Sell	12,301 -201	-2%	-$64.5K	0.59%	32
2017 Q3	$3.92M	Sell	12,502 -178	-1%	-$52.7K	0.59%	29
2017 Q2	$3.44M	Sell	12,680 -32	-0.3%	-$8.46K	0.53%	33
2017 Q1	$3.48M	Sell	12,712 -276	-2%	-$78K	0.54%	37
2016 Q4	$3.68M	Buy	12,988 +2,569	+25%	+$762K	0.56%	34
2016 Q3	$3.26M	Sell	10,419 -8,472	-45%	-$2.51M	0.5%	45
2016 Q2	$4.57K	Sell	18,891 -783	-4%	-$206K	0.34%	74
2016 Q1	$5.12M	Buy	19,674 +423	+2%	+$112K	0.41%	63
2015 Q4	$5.9M	Buy	19,251 +36	+0.2%	+$10.3K	0.5%	52
2015 Q3	$5.61M	Buy	19,215 +6,121	+47%	+$2.02M	0.46%	50
2015 Q2	$5.29K	Sell	13,094 -513	-4%	-$206K	0.79%	30
2015 Q1	$5.75K	Buy	13,607 +2,003	+17%	+$789K	0.84%	30
2014 Q4	$3.94M	Buy	11,604 +140	+1%	+$45.3K	0.54%	36
2014 Q3	$3.79M	Sell	11,464 -427	-4%	-$141K	0.52%	38
2014 Q2	$3.75M	Sell	11,891 -514	-4%	-$155K	0.51%	38
2014 Q1	$3.79M	Sell	12,405 -2,889	-19%	-$917K	0.47%	38
2013 Q4	$4.28M	Sell	15,294 -1,658	-10%	-$429K	0.52%	37
2013 Q3	$4.08M	Sell	16,952 -12,684	-43%	-$2.84M	0.52%	32
2013 Q2	$6.38M	Buy	+29,636	New	+$6.33M	0.78%	20

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arden Trust's BIIB Position: Q2 2024 in Review

Arden Trust held its Biogen (BIIB) position steady in Q2 2024 at 1,781 shares worth $413K. The position accounts for 0.06% of the portfolio, ranked #154.

Arden Trust first reported a position in BIIB in Q2 2013 and has held it in 45 quarters since. The position peaked at $6.38M in Q2 2013. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

Arden Trust held 1,781 shares of Biogen worth $413K as of Q2 2024.
Arden Trust left its Biogen share count unchanged in Q2 2024.
Biogen made up 0.06% of Arden Trust's portfolio in Q2 2024, its #154 holding.
Arden Trust first reported a position in Biogen in Q2 2013 and has held it in 45 quarters since.
Arden Trust's Biogen position peaked at $6.38M in Q2 2013.
943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Arden Trust's 13F filing for Q2 2024, filed 9 Jul 2024.